Study | Country | Methods | Prostate cancer | Prostate non cancer controls | P value |
---|---|---|---|---|---|
Hrbacek 2011 M. hominis [88] | Czech Republic | Serology | 60/330 18% | 16/107 14% | 0.518Â ns |
Hrbacek 2011 M. urealyticum [88] | Czech Republic | Serology | 64/328 20% | 11/105 11% | 0.068Â ns |
Barykova 2011Â M. hominis [123] | Russia US | Serology PCR | 28/125 22% 5/27 19% | 0/27 0% 4/31 13% | 0.023Â s |
Urbanek 2011 M. hyorhinus [125] | US | Serology | 59/114 52% | 38/105 36% | 0.279Â ns |
Erturhan 2013 [126] | Turkey | PCR | 11/31 35% | 0/31 0% | 0.004Â s |
Yow 2014 M. genitalium [127] | Australia | PCR | 9/115 8% | 1/51 2% | 0.163Â ns |
Miyake 2019 M. genitalium [128] | Japan | PCR | 18/45 40% | 6/33 18% | 0.127Â ns |
Saadat 2020 M. Hominis [129] | Iran | PCR | 8/61 13% | 0/70 0% | 0.003Â s |